共 35 条
[1]
Harris C.C., Hollstein M., Clinical implications of the p53 tumour-suppressor gene, N Engl J Med, 329, pp. 1318-1327, (1993)
[2]
Hollstein M., Sidransky D., Vogelstein B., Harris C.C., P53 mutations in human cancers, Science, 253, pp. 49-53, (1991)
[3]
Bos J.L., Ras oncogenes in human cancer: A review, Cancer Res, 49, pp. 4682-4689, (1989)
[4]
Levine A.J., Momand J., Finlay C.A., The p53 tumour suppressor gene, Nature, 351, pp. 453-456, (1991)
[5]
Vogelstein B., Kinzler K.W., P53 function and dysfunction, Cell, 70, pp. 523-526
[6]
Barnes D.M., Hanby A.M., Gillett C.E., Mohammed S., Hodgson S., Bobrow L.C., Et al., Abnormal expression of wild type of p53 protein in normal cells of a cancer family patient, Lancet, 340, pp. 259-263
[7]
Hsu I.C., Metcalf R.A., Sunt T., Welsh J.A., Wang N.J., Harris C.C., Mutational hotspot in the p53 gene in human hepatocellular carcinomas, Nature, 350, pp. 427-428, (1991)
[8]
Hosono S., Chou M.-J., Lee C.-S., Shih C., Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas, Oncogene, 8, pp. 491-496, (1993)
[9]
Challen C., Lunec J., Warren W., Collier J., Bassendine M.F., Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain, Hepatology, 16, pp. 1362-1366, (1992)
[10]
Kress S., Jahn U.-R., Buchmann A., Bannasch P., Schwarz M., P53 mutations in human hepatocellular carcinomas from Germany, Cancer Res, 52, pp. 3220-3223, (1992)